Exact Sciences
EXAS
#1382
Rank
NZ$21.15 B
Marketcap
$114.49
Share price
2.34%
Change (1 day)
-9.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total debt

Total debt on the balance sheet as of June 2024 : NZ$4.46 B

According to Exact Sciences's latest financial reports the company's total debt is NZ$4.46 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Exact Sciences - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$4.03 B4.82%
2022-12-31NZ$3.85 B10.8%
2021-12-31NZ$3.47 B7.34%
2020-12-31NZ$3.24 B128.89%
2019-12-31NZ$1.41 B37.84%
2018-12-31NZ$1.02 B16288%
2017-12-31NZ$6.26 M-20.97%
2016-12-31NZ$7.92 M-9.89%
2015-12-31NZ$8.79 M132.12%
2014-12-31NZ$3.79 M-28.69%
2013-12-31NZ$5.31 M113.22%
2012-12-31NZ$2.49 M94.58%
2011-12-31NZ$1.28 M-1.54%
2010-12-31NZ$1.3 M-52.8%
2009-12-31NZ$2.75 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
NZ$0.23 B-94.81%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.52 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.73 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.15 B 821.94%๐Ÿ‡ซ๐Ÿ‡ท France